Driven by high failure rates in bone-to-tendon repair and increasing recognition of the enthesis as a critical biomechanical interface, these expanded indications are projected to increase the total ...
LOS ANGELES, May 20, 2025 /PRNewswire/ -- Tetrous, Inc., a Sherman Oaks-based company focused on biologic solutions for bone-to-tendon healing, announces expanded clinical use of its EnFix implants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback